The Hunter Syndrome Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.5 billion by 2034, registering a CAGR of 7.5%. This growth trajectory is underpinned by several key factors, including rising awareness of rare diseases, advancements in treatment options, and increasing investments in research and development. The market is characterized by a growing demand for...